Zoetis (ZTS) Cash from Investing Activities Growth (1y) (2013 - 2026)
Powered by 
Analysis
Zoetis (ZTS) Cash from Investing Activities Growth (1y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.69 Bn | 40.49 Bn | 779.09 Mn | 24.18% |
| 2 | Zoetis | 30.63 Bn | 28.95 Bn | 1.05 Bn | -41.51% |
| 3 | Elanco Animal Health | 11.77 Bn | 11.24 Bn | 798.00 Mn | -96.43% |
| 4 | Phibro Animal Health | 1.49 Bn | 1.41 Bn | 134.40 Mn | -133.88% |
| 5 | Immucell | 90.19 Mn | 81.33 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 76.23 Mn | 69.14 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -41.51% |
| Mar 31, 2026 | 57.14% |
| Dec 31, 2025 | -231.75% |
| Sep 30, 2025 | 6.18% |
| Jun 30, 2025 | -60.61% |
| Mar 31, 2025 | -54.96% |
| Dec 31, 2024 | 160.00% |
| Sep 30, 2024 | 34.32% |
| Jun 30, 2024 | -65.00% |
| Mar 31, 2024 | 39.35% |
| Dec 31, 2023 | 52.05% |
| Sep 30, 2023 | -118.55% |
| Jun 30, 2023 | 60.59% |
| Mar 31, 2023 | -83.05% |
| Dec 31, 2022 | -208.45% |
| Sep 30, 2022 | -8.77% |
| Jun 30, 2022 | -46.04% |
| Mar 31, 2022 | -87.30% |
| Dec 31, 2021 | 19.77% |
| Sep 30, 2021 | 34.48% |